Product Liability Insurance in India: A Manufacturer's Complete Guide

For decades, product liability in India operated under a fragmented legal regime: consumers had to pursue negligence claims through civil courts, with the burden of proof resting squarely on the injured party. The Consumer Protection Act, 2019 (CPA 2019), which came into force on July 20, 2020, fundamentally altered this market. Chapter VI, comprising Sections 82 through 87, introduced a dedicated product liability framework that imposes strict liability on manufacturers, product service providers, and product sellers for harm caused by defective products.

Under Section 84 of the CPA 2019, a manufacturer is liable if the product contains a manufacturing defect, a design defect, deviates from express warranties, or lacks adequate instructions or warnings regarding proper usage. Critically, the consumer no longer needs to prove negligence; merely that the product was defective and that the defect caused harm. This represents a approach shift from the fault-based liability that governed the earlier Consumer Protection Act, 1986.

The practical implications for Indian manufacturers are substantial. The National Consumer Disputes Redressal Commission (NCDRC) and State Commissions have already begun adjudicating claims under the new provisions, with compensation awards trending upward. In the automotive sector alone, recall orders from SIAM-coordinated voluntary recalls exceeded 1.5 million vehicles in recent years, each representing a potential liability event.

Product liability insurance, historically an afterthought for Indian manufacturers who relied on general commercial policies, is now an essential component of enterprise risk management. Without dedicated coverage, a single product liability claim under CPA 2019 can expose a manufacturer to unlimited compensatory damages, including punitive damages in egregious cases.

The CPA 2019's product liability provisions deserve careful examination because they define the contours of insurable risk. Section 82 establishes that every product liability action may be brought by a complainant against a product manufacturer, product service provider, or product seller, creating multiple potential defendants in a single claim.

Section 83 defines the grounds on which a product liability action may be brought. For manufacturers specifically, Section 84 enumerates six grounds: (a) the product contains a manufacturing defect; (b) the product is defective in design; (c) there is a deviation from manufacturing specifications; (d) the product does not conform to the express warranty; (e) the product fails to contain adequate instructions for correct usage to prevent harm; and (f) the product fails to contain adequate warnings regarding improper or incorrect usage.

Section 85 addresses liability of product service providers, while Section 86 covers product sellers. Relevant when a manufacturer also operates as a direct seller through e-commerce channels. Section 87 provides limited exceptions: a product seller is not liable if they did not exercise substantial control over the product's design, testing, or labelling. However, no such blanket exception exists for manufacturers.

Beyond the CPA 2019, manufacturers must also consider the Bureau of Indian Standards Act, 2016, which mandates BIS certification for products covered under compulsory registration orders. Non-compliance with BIS standards (currently covering over 370 product categories) can serve as prima facie evidence of a manufacturing or design defect in product liability proceedings. Similarly, the Food Safety and Standards Act, 2006, administered by FSSAI, imposes strict product safety requirements on food manufacturers, and FSSAI-ordered recalls directly implicate product liability exposure.

The Legal Metrology Act, 2009, and the Drugs and Cosmetics Act, 1940, create additional compliance obligations whose breach can trigger or aggravate product liability claims.

Product liability insurance policies in India typically respond to three categories of coverage triggers, each requiring distinct underwriting analysis.

A manufacturing defect arises when a specific unit or batch deviates from the manufacturer's own intended specifications, even though the design itself is sound. For example, a pharmaceutical company that produces a batch of tablets with incorrect dosage concentrations due to a calibration error on the production line has a manufacturing defect. Indian courts have recognised this distinction: the NCDRC in its rulings has differentiated between isolated batch failures and systemic product issues.

A design defect exists when the entire product line is inherently unsafe due to flawed design, even when manufactured exactly as intended. The legal test applied in Indian courts, drawing from the CPA 2019's language, examines whether a reasonable alternative design existed that would have reduced the risk of harm without substantially impairing the product's utility. Automotive component failures, such as airbag deployment defects or brake system design flaws, frequently fall into this category.

Failure to warn, codified in Section 84(e) and (f) of the CPA 2019, covers scenarios where the product itself is not defective but the manufacturer failed to provide adequate instructions for safe use or warnings about foreseeable misuse. This is particularly relevant for industrial chemicals, where Safety Data Sheets (SDS) must comply with BIS IS 17206:2019 (aligned with the Globally Harmonised System). Inadequate labelling of consumer electronics, machinery operating manuals, and pharmaceutical patient information leaflets also fall under this trigger.

Underwriters evaluating product liability proposals must assess which of these triggers presents the greatest exposure for the specific manufacturer. A pharmaceutical company faces significant manufacturing defect risk due to batch processing, while a consumer electronics manufacturer may have more exposure to design defect and failure-to-warn claims. This assessment directly informs coverage structure, sub-limits, and deductible calibration.

Product liability insurance in India is underwritten as a standalone policy or as a section within a Commercial General Liability (CGL) policy. IRDAI does not prescribe a mandatory policy wording for product liability, unlike the Standard Fire and Special Perils Policy. Instead, insurers file their own wordings with IRDAI under the File and Use procedure governed by the IRDAI (Insurance Products) Regulations, 2024.

The typical Indian product liability policy provides indemnity against legal liability to pay compensation to third parties for bodily injury or property damage caused by a defective product manufactured, sold, or distributed by the insured. The insuring clause is generally written on a claims-made basis — meaning the claim must be first made against the insured during the policy period, regardless of when the defect originated or the injury occurred. Some insurers offer occurrence-based triggers, but claims-made is the dominant form in the Indian market.

Key policy components include the limit of indemnity (expressed as an aggregate annual limit and sometimes with per-claim sub-limits), the retroactive date (the earliest date from which claims arising out of past products are covered), and the extended reporting period (ERP or tail cover), which allows the insured to report claims after policy expiry for events that occurred during the policy period.

Standard exclusions typically include: contractual liability beyond that which would exist at law, product recall costs (which require a separate recall policy), fines and penalties imposed under statute, claims arising from products known to be defective at inception, war and nuclear exclusions, and claims arising from wilful non-compliance with regulatory standards. The recall exclusion is particularly significant, while the CPA 2019 empowers the Central Authority to order product recalls under Section 20, the cost of executing a recall (retrieval, replacement, consumer notification, logistics) is not covered under a standard product liability policy.

Brokers negotiating on behalf of manufacturers should pay close attention to the territorial scope (whether the policy covers products exported from India), the jurisdiction clause (especially if the manufacturer exports to litigious markets like the United States), and whether defence costs are payable within or in addition to the limit of indemnity.

Understanding product liability exposure requires examining real-world claim patterns across India's key manufacturing sectors.

In FMCG and food processing, product liability claims most frequently arise from contamination events. FSSAI's enforcement actions (including product recalls for excessive pesticide residues, presence of undeclared allergens, and microbiological contamination) create immediate liability exposure. A packaged food manufacturer whose product causes a food-borne illness outbreak faces claims from multiple consumers simultaneously, and the CPA 2019's class action provisions (Section 35) amplify this risk. The NCDRC has consistently held food manufacturers to strict liability standards, with compensation awards covering medical expenses, lost income, and pain and suffering.

The automotive sector faces product liability exposure primarily through design defects and component failures. Under the Motor Vehicles Act, 1988 (as amended in 2019), vehicle manufacturers are already subject to recall obligations. Product liability claims may arise from defective airbags, brake failures, fuel system leaks, or structural integrity issues. The high cost of automotive product liability is driven by the severity of bodily injury claims and the potential for class-action-style proceedings when a defect affects an entire model line.

Pharmaceutical manufacturers face perhaps the most complex product liability space. The Drugs and Cosmetics Act, 1940 (amended 2008), read with the CPA 2019, creates overlapping compliance and liability obligations. Manufacturing defects (contamination, incorrect API concentration), design defects (inadequate clinical trial data for an approved formulation), and failure-to-warn claims (insufficient adverse event disclosures) all present material exposure. The NCDRC's rulings in pharmaceutical liability cases have increasingly referenced international pharmacovigilance standards, raising the bar for what constitutes adequate warning.

Industrial machinery and electrical equipment manufacturers face claims primarily under the failure-to-warn trigger and from manufacturing defects that cause workplace injuries. The Factories Act, 1948, and the Occupational Safety, Health and Working Conditions Code, 2020, create a regulatory backdrop against which product liability claims are assessed.

Determining the appropriate limit of indemnity for a product liability policy requires a structured analysis rather than arbitrary benchmarking. Indian manufacturers frequently under-insure for product liability, purchasing limits of INR 1-5 crore when their actual exposure may be several multiples higher.

The starting point is a maximum probable loss (MPL) assessment specific to product liability. This requires estimating: (a) the maximum number of individuals who could be harmed by a single defective product or batch; (b) the average compensation per claimant, benchmarked against NCDRC and State Commission awards in the relevant product category; (c) defence costs, which in complex product liability litigation can equal or exceed the compensation amount; and (d) the potential for regulatory penalties and recall costs (the latter requiring a separate recall policy).

For FMCG manufacturers with national distribution, the aggregation risk is substantial. A contaminated batch that reaches thousands of retail outlets before detection could generate hundreds of simultaneous claims. A limit of INR 25-50 crore may be appropriate for a mid-sized FMCG manufacturer, with higher limits for companies with export exposure.

Automotive component manufacturers, particularly those supplying to OEMs under JIT arrangements, should structure limits that reflect the downstream liability chain. An OEM facing a class-action recall will seek contribution from component suppliers, and the contractual indemnity clauses in supply agreements typically require the component manufacturer to carry product liability limits of INR 50-100 crore or higher.

Pharmaceutical manufacturers must consider the global nature of their distribution. A company exporting Active Pharmaceutical Ingredients (APIs) to regulated markets faces exposure under those jurisdictions' product liability regimes, which may impose significantly higher damages than Indian courts. Limits of INR 100 crore or more are common for mid-sized pharma exporters.

Deductibles should be calibrated to the insured's risk retention capacity and claims frequency expectations. A self-insured retention of INR 5-10 lakh per claim is typical for SME manufacturers, while large corporates may retain INR 25-50 lakh or more. Higher deductibles reduce premium cost but require sound internal claims management capabilities.

A product liability policy's value is defined as much by its exclusions as by its insuring clause. Indian manufacturers and their brokers must scrutinise exclusions carefully, as several standard exclusions can create significant coverage gaps.

The product recall exclusion is the most consequential gap in a standard product liability policy. While the policy covers bodily injury and property damage caused by a defective product, it does not cover the cost of recalling the product from the market. Given that the Central Consumer Protection Authority (CCPA) under CPA 2019 has the power to order product recalls under Section 20, and FSSAI routinely mandates recalls for food products, manufacturers must procure a separate product recall insurance policy to cover retrieval costs, replacement costs, business interruption during the recall, and third-party logistics expenses.

The known defect or prior knowledge exclusion bars claims arising from defects the insured was aware of before the policy inception date. This exclusion requires careful disclosure at the proposal stage; if a manufacturer has received consumer complaints about a potential defect, failure to disclose this information can void coverage entirely under Section 45 of the Insurance Act, 1938 (as applicable to non-life through judicial interpretation).

The contractual liability exclusion limits coverage to liability that would exist at law, excluding enhanced obligations assumed under contract. However, in practice, OEM supply agreements routinely require suppliers to indemnify for all product-related losses. Manufacturers should negotiate a contractual liability extension, which most Indian insurers will provide for an additional premium.

Punitive or exemplary damages are excluded under most Indian product liability policies. While Indian courts have historically been conservative in awarding punitive damages, the CPA 2019 has expanded consumer forums' remedial powers, and recent NCDRC decisions suggest a willingness to impose exemplary damages in cases of gross negligence or wilful non-compliance with safety standards.

Other exclusions to negotiate include the professional advice exclusion (relevant for manufacturers who provide technical consulting alongside product supply), the efficacy exclusion (critical for pharmaceutical and agrochemical manufacturers), and territorial limitations (ensure export markets are covered if the manufacturer ships products internationally).

Insurance is a financial backstop, not a substitute for product safety. Indian manufacturers should build a thorough product liability risk management programme that reduces both the frequency and severity of potential claims while improving their insurability and premium terms.

The foundation is a quality management system certified to ISO 9001:2015, supplemented by industry-specific standards: ISO 22000 for food safety, IATF 16949 for automotive supply chain, GMP compliance under Schedule M of the Drugs and Cosmetics Rules for pharmaceuticals, and the relevant BIS standards applicable to the product category. Compliance with these standards does not provide immunity from product liability, but it demonstrates due diligence and can reduce the quantum of damages awarded.

Product testing and documentation are critical. Manufacturers should maintain complete batch records, raw material traceability (from supplier to finished product), and retain samples for the product's expected shelf life plus the applicable limitation period for product liability claims under the CPA 2019. The limitation period is two years from the date the cause of action arises, but given that latent defects may not manifest for years, retaining records for at least five to seven years is prudent practice.

A formal product recall plan should be documented, tested annually, and aligned with the CCPA's recall powers under Section 20 of the CPA 2019. The plan should define recall triggers, communication protocols, logistics arrangements, regulatory notification procedures (to FSSAI for food, CDSCO for drugs, BIS for certified products), and financial provisioning.

Contractual risk transfer is an essential complement to insurance. Manufacturers should ensure that supply agreements with raw material and component suppliers include indemnity clauses, require suppliers to carry their own product liability insurance with the manufacturer named as an additional insured, and specify minimum coverage limits. Equally, manufacturers should review the indemnity clauses in their downstream supply agreements with distributors and OEMs to understand the scope of their assumed obligations.

Finally, engagement with an experienced insurance broker who specialises in liability placements can materially improve both coverage terms and premium. A broker who understands the manufacturer's production processes, quality systems, and distribution chain can present the risk to underwriters in a manner that secures broader coverage and more competitive pricing.